Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research

Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research

ABSTRACT Pulmonary arterial hypertension (PAH) requires lifelong medication, with patients taking an average of 12 tablets/day. Several chronic diseases can be treated with a fixed‐dose combination (FDC) tablet, decreasing patient pill burden and increasing adherence. This exploratory research, cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Jean M. Elwing, Stacey Barta, Tim Smith, Gabriela Gomez Rendon, David Lopez, Wesley Peters, Marinella Sandros, Akshay Muralidhar
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Pulmonary Circulation
Subjects:
fixed‐dose combination therapy
patient perspective
pulmonary hypertension
qualitative
Online Access:https://doi.org/10.1002/pul2.70098
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/pul2.70098

Similar Items